Obstructive Sleep Apnea (OSA): Rare and Atypical Presentations

Why Atypical OSA Presentations Matter

The classic OSA triad (loud snoring, witnessed apneas, and excessive daytime sleepiness) captures only a fraction of the real disease burden. A 2019 JAMA Internal Medicine analysis found that roughly 80% of moderate-to-severe OSA cases in community samples remain undiagnosed [1]. Missed diagnoses translate directly to untreated cardiovascular risk, worsening metabolic syndrome, and impaired neurocognitive performance.

The Cost of Diagnostic Anchoring

When clinicians anchor on the "typical" patient, they systematically miss women, children, and lean individuals. A retrospective cohort study published in the European Respiratory Journal (N=2,799) showed that women waited a mean of 3.6 additional years from symptom onset to diagnosis compared with men [2]. That lag is not trivial. The Wisconsin Sleep Cohort demonstrated that an apnea-hypopnea index (AHI) of 15 or higher was associated with a 3-fold increased risk of all-cause mortality over 18 years [3].

What "Rare" Actually Means Here

The presentations described below are not vanishingly uncommon. Each pattern constitutes at least 5-25% of OSA cases in specialty sleep clinic populations. They are called atypical only because they fall outside the most-cited screening criteria, not because they are medically exotic.

Silent OSA: Apnea Without the Snoring

Snoring is absent in a meaningful minority of confirmed OSA patients. Estimates range from 13% to 22% depending on how habitual snoring is defined [4]. Patients with silent OSA often present instead with morning headaches, unrefreshing sleep, or mild cognitive complaints.

Mechanisms Behind Non-Snoring OSA

Snoring requires partial obstruction; complete or near-complete obstruction can silence the airway. Patients with redundant lateral pharyngeal wall tissue, rather than a floppy palate, tend to close quietly. Positional factors also play a role: some patients obstruct only when supine but snore only briefly before arousal, so bed partners report nothing.

Clinical Red Flags for Silent OSA

• Morning headaches (particularly occipital) that resolve within 30-60 minutes of waking
• Unexplained polycythemia or a hematocrit above 50% in a non-smoking patient
• Pulmonary hypertension without an identifiable cardiac or parenchymal lung cause
• Nocturnal oxygen desaturation found incidentally on overnight oximetry ordered for another reason

The American Academy of Sleep Medicine (AASM) 2017 Clinical Practice Guidelines note that overnight oximetry alone carries insufficient sensitivity to rule out OSA and recommend full polysomnography or a validated home sleep apnea test when clinical suspicion persists regardless of self-reported snoring [5].

OSA in Women: The Most Under-Recognized Presentation

Women account for 26% of OSA diagnoses but represent roughly 40% of the true disease burden. The female phenotype diverges from the male archetype in almost every symptom domain.

Symptom Profile Differences

Women with OSA report insomnia, fatigue, depression, and restless legs at substantially higher rates than men with equivalent AHI values [6]. In the Sleep Heart Health Study (N=6,441), women were significantly more likely to endorse fatigue as their primary complaint rather than sleepiness per se, a distinction that matters because most screening questionnaires (Epworth, STOP-BANG) are weighted toward sleepiness [3].

Snoring in women is also perceived differently. Social desirability bias causes women to under-report their own snoring, and bed partners may not recognize female snoring as pathological.

Hormonal Inflection Points

Progesterone acts as a mild respiratory stimulant. Before menopause, this protects women against upper airway collapse. After menopause, OSA prevalence in women rises to approach that of men the same age. The Wisconsin Sleep Cohort found a 3.5-fold increase in OSA prevalence after menopause, and hormone therapy was associated with approximately half the OSA prevalence in postmenopausal women compared with those not using hormones [7].

Pregnancy adds a separate risk window. Upper airway edema, weight gain, and supine positioning all increase AHI. A 2014 meta-analysis (N=3,705 pregnant women) found OSA was present in 3.6% of the sample and was independently associated with gestational hypertension and preeclampsia [8].

Screening Adjustment for Women

The standard STOP-BANG questionnaire (sensitivity ~84% for men with moderate-to-severe OSA) performs significantly worse in women. A modified scoring threshold of 2 instead of 3 on STOP-BANG has been proposed for female patients to recover sensitivity. The Berlin Questionnaire similarly requires clinical recalibration in women. Until validated female-specific tools are widely adopted, clinicians should lower their polysomnography referral threshold by at least one point on any composite screening score when evaluating women.

Pediatric OSA: When the Patient Cannot Describe Sleep

Children with OSA rarely report sleepiness. Instead, they present with hyperactivity, poor school performance, behavioral problems, enuresis, and mouth breathing. This overlap with attention-deficit/hyperactivity disorder (ADHD) leads to a median diagnostic delay of 2 years in affected children.

Adenotonsillar Disease as the Primary Driver

Adenotonsillar hypertrophy accounts for the majority of pediatric OSA. A randomized controlled trial (CHAT trial, N=464, NEJM 2013) found that adenotonsillectomy normalized polysomnographic findings in 79% of children at 7 months versus 46% in the watchful-waiting group [9]. The CHAT trial also documented significant improvements in behavior and quality of life, though a modest improvement occurred in both groups.

When the Tonsils Are Not Enlarged

Obesity-related pediatric OSA is rising. Data from the Childhood Adenotonsillectomy Trial and subsequent registry analyses show that obese children have more persistent post-operative OSA, higher residual AHIs, and greater positional dependence than non-obese counterparts [9]. Children with Down syndrome, Pierre Robin sequence, Prader-Willi syndrome, or achondroplasia also carry high OSA risk independent of tonsil size due to craniofacial and neuromuscular factors.

Key Diagnostic Differences in Children

The AASM defines pediatric OSA as an obstructive AHI of 1 or more events per hour, versus 5 per hour in adults, because children have higher arousal thresholds and tolerate longer obstructive events before waking [5]. A normal adult home sleep apnea test report can still represent significant disease in a child. Attended polysomnography in a pediatric sleep laboratory remains the gold standard.

REM-Related OSA

REM-related OSA is defined as an AHI during REM sleep that is at least 2 times greater than the NREM AHI, with the overall AHI not reaching the threshold for a standard OSA diagnosis [10]. It affects an estimated 10-36% of patients referred to sleep clinics.

Why REM Selectively Worsens Obstruction

During REM sleep, motor neuron activity at the hypoglossal nucleus is suppressed, reducing genioglossal muscle tone and increasing upper airway collapsibility. Respiratory rate also becomes irregular and chemoreceptor responsiveness diminishes. Together, these changes make the upper airway profoundly vulnerable.

Who Gets REM-Related OSA

Women account for 58-65% of REM-related OSA cases [10]. Because REM sleep concentrates in the second half of the night, patients who sleep fewer than 7 hours or who sleep with interruptions may have most of their REM-stage events cut off, producing a falsely low overall AHI on home sleep apnea testing. A full in-laboratory polysomnography that captures adequate REM is the preferred diagnostic study when REM-related OSA is suspected.

Clinical Implications

Whether REM-related OSA carries independent cardiovascular risk comparable to pan-stage OSA is still under study. A 2021 cross-sectional analysis (N=5,765, Sleep Medicine journal) found that isolated REM-related OSA was associated with higher rates of hypertension and metabolic syndrome even when NREM AHI was normal [10]. Standard CPAP titration addresses REM-related disease, though some patients require supplemental pressure support specifically during REM stages.

Positional OSA

Positional OSA (POSA) is defined as an overall AHI of at least 5 events per hour, with a supine AHI at least twice the non-supine AHI, and a non-supine AHI below 5 events per hour in the mild-to-moderate classification. It affects 56-75% of mild-to-moderate OSA patients.

The Gravity Effect on the Upper Airway

In the supine position, the tongue and soft palate fall posteriorly under gravity, narrowing the retropalatal and retroglossal spaces. Lateral positioning shifts this load and can normalize breathing entirely. A study published in the Journal of Clinical Sleep Medicine (N=574) found that 31% of patients with supine AHI exceeding 20 had a non-supine AHI below 5 [11].

Positional Therapy Options

Positional therapy devices, including vibrotactile trainers worn at the chest or back, are approved alternatives to CPAP for confirmed POSA. A randomized crossover trial comparing a chest-worn vibrotactile device (NightShift) against CPAP in POSA patients showed comparable AHI reduction and better patient-reported adherence over 3 months [11]. Standard CPAP remains appropriate for patients who cannot tolerate positional devices or whose non-supine AHI remains elevated.

OSA in Lean and Normal-Weight Patients

The assumption that OSA requires obesity excludes 25-30% of actual OSA patients. In Asian populations, the proportion of normal-weight OSA patients rises to 40-60%, partly due to craniofacial skeletal differences that reduce pharyngeal airspace even without excess adiposity [12].

Anatomical Factors That Operate Independently of Weight

• Retrognathia and micrognathia reduce retroglossal space regardless of BMI
• Low hyoid position is an independent predictor of OSA severity (multivariate-adjusted OR 2.4 per centimeter of inferior displacement)
• High, narrow hard palate compresses the nasal passage and forces mouth breathing
• Macroglossia, as seen in acromegaly or hypothyroidism, narrows the oropharynx directly

Acromegaly deserves specific mention. Growth hormone excess causes tongue hypertrophy, facial bone remodeling, and prognathism reversal over time. OSA prevalence in acromegaly reaches 60-80% [13]. Effective treatment of acromegaly with a somatostatin analog (e.g., octreotide or lanreotide) reduces but does not always resolve OSA, and ongoing CPAP titration is required even after biochemical remission.

Hypothyroidism and OSA

Hypothyroidism contributes to OSA through two mechanisms: myxedematous infiltration of pharyngeal soft tissue and reduced hypoglossal neuromuscular drive. A systematic review in the European Journal of Endocrinology (N=1,278 across 14 studies) found OSA prevalence of 30-40% in overt hypothyroidism [13]. Levothyroxine replacement to euthyroidism reduces OSA severity in some but not all patients; sleep study reassessment 3-6 months after reaching target TSH is standard practice.

Upper Airway Resistance Syndrome: OSA's Closest Neighbor

Upper Airway Resistance Syndrome (UARS) represents a state of increased respiratory effort without discrete apneas or hypopneas sufficient to meet standard AHI thresholds. The AHI is typically below 5, yet patients show frequent arousals on electroencephalography (EEG) driven by respiratory effort-related arousals (RERAs).

Distinguishing UARS from OSA

Standard home sleep apnea tests undercount RERAs because they require nasal pressure or effort-belt signals plus EEG to identify arousal-associated events. A patient with an in-home AHI of 2 but 40 RERAs per hour has clinically significant sleep-disordered breathing missed entirely by conventional scoring.

The AASM 2012 scoring rules folded most UARS events into hypopnea scoring when esophageal manometry was unavailable, effectively collapsing UARS into mild OSA diagnostically, though the distinction retains clinical utility for explaining symptom severity disproportionate to AHI [5].

Who Develops UARS

UARS disproportionately affects young, thin women who present with chronic fatigue, orthostatic intolerance, functional somatic symptoms, and unrefreshing sleep. The phenotypic overlap with fibromyalgia and dysautonomia is notable and has been documented in specialty clinic series. Treatment response to CPAP or expiratory positive airway pressure (EPAP) devices is variable; a pressure titration study is needed.

OSA Presenting as Cardiovascular Disease

A subset of OSA patients comes to clinical attention first through cardiovascular rather than sleep complaints. Resistant hypertension (blood pressure uncontrolled on three antihypertensives at full doses) carries an OSA prevalence of 64-83% [14]. The 2018 AHA/ACC Hypertension Guideline explicitly recommends screening for secondary causes including OSA in all patients with resistant hypertension.

Nocturnal atrial fibrillation is another presentation route. OSA causes intermittent hypoxia, negative intrathoracic pressure swings, and autonomic activation that remodel atrial electrophysiology. A landmark study in the Journal of the American College of Cardiology (N=10,132) found that untreated OSA was associated with a 2.18-fold higher rate of AF recurrence after cardioversion compared with effectively treated OSA [14].

Nocturnal ST-segment depression discovered during Holter monitoring or sudden death during sleep, while rare, should prompt sleep study referral when no structural cardiac cause is identified.

OSA in Older Adults: Atypical Because Age Changes Everything

OSA prevalence rises steeply with age. Among adults over 65, prevalence estimates using an AHI threshold of 15 reach 34-45% [15]. Yet older adults less commonly report sleepiness, partly because reduced sleep drive and higher arousal thresholds blunt subjective awareness of fragmented sleep.

Cognitive Decline as the Presenting Complaint

Mild cognitive impairment and early dementia can be the presenting feature of severe untreated OSA in older adults. Intermittent hypoxia promotes amyloid deposition and tau phosphorylation. A 2023 study in JAMA Neurology (N=4,257 older adults followed for 10 years) found that OSA with oxygen desaturation index above 15 was associated with a 34% higher risk of incident Alzheimer disease, independent of APOE-e4 genotype [15].

CPAP trials in older adults with MCI have shown modest but statistically significant improvements in delayed recall and executive function at 3 and 6 months compared with sham CPAP, though trial sizes remain small.

Putting the Atypical Patterns Together: A Diagnostic Framework

Recognizing atypical OSA requires expanding the screening net beyond the Epworth plus STOP-BANG approach. The following patterns should each trigger objective sleep testing regardless of classic symptom profile:

1. Resistant or nocturnal-predominant hypertension unresponsive to 2 agents
2. Unexplained morning headaches in a non-obese patient
3. Chronic fatigue or insomnia in a perimenopausal or postmenopausal woman
4. Behavioral or academic problems in a child who breathes through the mouth
5. New-onset atrial fibrillation or frequent nocturnal premature atrial contractions
6. Overt hypothyroidism or active acromegaly, regardless of BMI or snoring history
7. Isolated nocturnal oxygen desaturation on pulse oximetry ordered for another reason
8. Polycythemia without a smoking or altitude explanation

The AASM recommends polysomnography over home sleep apnea testing when pre-test probability of a non-OSA sleep disorder is high, when the patient cannot operate a home device independently, or when a pediatric patient is being evaluated [5].